Health Care Sector Update for 08/05/2020: NVAX, CORT, GNMK, VHT, IYH, IBB, XLV

Health care stocks were trading flat-to-higher during premarket on Wednesday. The Vanguard Health Care ETF (VHT) and the iShares Dow Jones US Healthcare (IYH) were unchanged, while the iShares NASDAQ Biotechnology Index (IBB) gained 0.67% and the Health Care SPDR (XLV) rose 0.64%.

Stocks moving on the news include Novavax (NVAX), which rose more than 19%. The biotechnology company said data from its Phase 1/2 trial for its COVID-19 vaccine candidate was found to be generally well-tolerated. There were also no severe adverse events recorded during the trial and the majority of adverse events were mild.

Corcept Therapeutics (CORT) retreated 6% after posting Q2 non-GAAP diluted net income of $0.32 per share, up from $0.25 per share a year earlier. Analysts polled by Capital IQ expected earnings of $0.21 per share. The company also reaffirmed its full-year 2020 revenue guidance of $355 million to $375 million.

GenMark Diagnostics (GNMK) declined by more than 4%. The company on Tuesday posted a Q2 adjusted non-GAAP net loss of $0.07 per share, compared with a loss of $0.23 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.11 per share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.